- Home
- BALY vs TSHA Comparison
BALY vs TSHA Comparison
Compare BALY & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BALY
- TSHA
- Stock Information
- Founded
- BALY 2004
- TSHA 2019
- Country
- BALY United States
- TSHA United States
- Employees
- BALY 10000
- TSHA N/A
- Industry
- BALY Hotels/Resorts
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- BALY Consumer Discretionary
- TSHA Health Care
- Exchange
- BALY Nasdaq
- TSHA Nasdaq
- Market Cap
- BALY 737.4M
- TSHA 728.4M
- IPO Year
- BALY N/A
- TSHA 2020
- Fundamental
- Price
- BALY $11.09
- TSHA $2.43
- Analyst Decision
- BALY Hold
- TSHA Strong Buy
- Analyst Count
- BALY 7
- TSHA 5
- Target Price
- BALY $18.00
- TSHA $8.20
- AVG Volume (30 Days)
- BALY 363.4K
- TSHA 3.5M
- Earning Date
- BALY 02-19-2025
- TSHA 08-11-2025
- Dividend Yield
- BALY N/A
- TSHA N/A
- EPS Growth
- BALY N/A
- TSHA N/A
- EPS
- BALY N/A
- TSHA N/A
- Revenue
- BALY $2,481,783,000.00
- TSHA $7,224,000.00
- Revenue This Year
- BALY $3.06
- TSHA N/A
- Revenue Next Year
- BALY N/A
- TSHA N/A
- P/E Ratio
- BALY N/A
- TSHA N/A
- Revenue Growth
- BALY 2.80
- TSHA N/A
- 52 Week Low
- BALY $9.74
- TSHA $1.05
- 52 Week High
- BALY $18.38
- TSHA $3.31
- Technical
- Relative Strength Index (RSI)
- BALY 57.77
- TSHA 47.43
- Support Level
- BALY $9.48
- TSHA $2.25
- Resistance Level
- BALY $15.00
- TSHA $2.48
- Average True Range (ATR)
- BALY 1.06
- TSHA 0.16
- MACD
- BALY 0.24
- TSHA -0.04
- Stochastic Oscillator
- BALY 40.26
- TSHA 36.73
About BALY Bally's Corporation
Ballys Corp is a gaming, hospitality, and entertainment company with a portfolio of casinos and resorts and a growing omnichannel presence. It provides customers with physical and interactive entertainment and gaming experiences, including traditional casino offerings, iGaming, online bingo, sportsbook, and free-to-play (F2P) games. The company owns and operates, several casinos across the United States, one golf course in New York, one horse racetrack in Colorado, and Aspers Casino in the United Kingdom. Its Interactive International division, an interactive gaming operator concentrated in Europe, operates a lottery management and services business. The company's reportable segments are Casinos and Resorts, which derive key revenue, International Interactive and North America Interactive.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.